TYMLOS (abaloparatide), from Radius Health, is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, and to increase bone density in men with osteoporosis at high risk for fracture.
Abaloparatide is a parathyroid hormone-related peptide (PTHrP) analog that stimulates new bone formation, helping to increase bone mineral density and reduce fracture risk.
TYMLOS may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:
The order is confirmed only after receipt and verification of a valid prescription.
TYMLOS is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).
Indian Pharma Network (IPN) can source TYMLOS from its authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.
For TYMLOS cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.
TYMLOS treats osteoporosis in postmenopausal women and men at high fracture risk.
TYMLOS is developed by Radius Health.
By once-daily subcutaneous injection using a prefilled pen, self-administered by the patient.
Cost depends on treatment duration and sourcing logistics — share your prescription with IPN for a quote.
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.
